Drug
Plecanatide
Plecanatide: highest development phase Phase 3, developed by Bausch Health. 4 trial records tracked on RxWires.
- Highest phase
- Phase 3
- Developer
- Bausch Health
Trials
| Drug | Phase | Indication |
|---|---|---|
| Plecanatide NCT02493452 | Phase 3 | Irritable Bowel Syndrome Characterized by Constipation |
| Plecanatide NCT03120520 | Phase 2 | Chronic Idiopathic Constipation |
| plecanatide NCT07723924 | Phase 2 | Functional Constipation (FC) |
| Plecanatide NCT03596905 | Phase 2 | Irritable Bowel Syndrome With Constipation |
Latest
No recent events.
Follow Plecanatide on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.